The Regulatory Center

Filter Your Results

 

News

 

CE Mark Approved for Medtronic’s Recapturable CoreValve Evolut R System

September 3, 2014 -- Medtronic, Inc. announced European CE Mark approval for the 23-mm CoreValve Evolut R system for transcatheter aortic valve replacement (TAVR). The device …

FDA Clears Oscor’s Adelante Magnum Introducer

August 28, 2014 -- Oscor Inc. announced 510(k) clearance from the US Food and Drug Administration to market the Adelante Magnum introducer in the United States. The device is …

CMS Interventional Cardiology Code to Take Effect in 2015

August 28, 2014 -- The Centers for Medicare & Medicaid Services (CMS) issued a “Medicare Learning Network” bulletin (MLN Matters) regarding the new CMS physici…

FDA Action Plan Addresses Gap in Clinical Data for Women and Minorities

August 20, 2014 -- The US Food and Drug Administration (FDA) announced the publication of the “FDA Action Plan to Enhance the Collection and Availability of Demographic …

St. Jude Medical’s CardioMems HF System Receives CMS Approval for New Technology Add-On Payment

August 5, 2014 -- St. Jude Medical, Inc. announced that the US Center for Medicare & Medicaid Services (CMS) has approved a New Technology Add-On Payment (NTAP) for the co…

CE Mark Approved for Boston Scientific’s Agent PTCA Balloon

July 23, 2014 -- Boston Scientific Corporation announced the CE Mark approval and European launch of the Agent paclitaxel-coated percutaneous transluminal coronary angioplasty…

FDA Approves Boston Scientific’s Bare-Metal Rebel PtCr Coronary Stent System

July 21, 2014 -- Boston Scientific Corporation announced that the bare-metal Rebel platinum chromium (PtCr) coronary stent system has received US Food and Drug Administration …

Boston Scientific Receives CE Mark Approval for 25-mm Lotus TAVR System

July 14, 2014 -- Boston Scientific Corporation announced that it has received European CE Mark approval for the 25-mm Lotus transcatheter aortic valve replacement (TAVR) syste…

 

advertisement

2018 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.